zaynich drug dcgi News and Updates from The Economic Times

Searched for

ZAYNICH DRUG DCGI

Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt shares jump 17%, hit fresh 52-week high
Wockhardt eyes USD 7 billion market opportunity for antibiotic Zaynich in US, Europe

- Wockhardt Q2 Results: Net loss narrows to Rs 16 crore, revenue rises 7%
  Drugmaker Wockhardt on Wednesday reported a net loss of Rs 16 crore in Q2FY25 led by improved performance across UK, India and emerging mar...
  13 Nov, 2024, 08.41 PM IST
Load More